Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 25, Issue 3, 2006, Pages 403-409

  Li, Qiang ^a   Xu, B ^a   Fu, L ^a   Hao, X S ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Carcinogenesis; Embolus; Growth factor; Hepatocellular carcinoma; Portal vein

Indexed keywords

ANGIOPOIETIN 2; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; EPHRIN B2; VASCULOTROPIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PORTAL VEIN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOGENESIS; VASCULAR TUMOR;

ANGIOPOIETIN-2; CARCINOMA, HEPATOCELLULAR; EPHRIN-B2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PORTAL VEIN; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED; VENOUS THROMBOSIS;

EID: 33751115483     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Pisani P., Parkin D.M., Bray F.I.: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83: 18-29,1999.
2. Akriviadis E.A., Llovet J.M., Efremidis S.C., et al: Hepatocellular carcinoma. Br. J. Surg. 85(10): 1319-1331,1998.
3. Tang Z.Y.: Hepatocellular carcinoma-cause, treatment and metastasis. World J. Gastroenterol. 7(4): 445-454,2001.
4. Folkman J., Klagsbrun M.: Angiogenic factors. Science 235(4787):442-447,1987.
5. Folkman J.: What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82(1):4-6,1990.
6. Folkman J.: Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med. 1(1):27-31,1995.
7. Araya M., Terashima M., Takagane A., et al: Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J. Surg. Oncol. 65(4):232-236,1997.
8. Hanahan D. and Folkman J.: Patterns and emerging mechanisms of the angiogenic switch during tumorgenesis. Cell 86(3):353-364, 1996.
9. Carmeliet P., Jain R.K.: Angiogenesis in cancer and other diseases. Nature 407 (6801): 249-257, 2000.
10. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J.: Vascular-specific growth factors and blood vessel formation. Nature 407 (6801): 242-248, 2000.
11. LeCouter J., Kowalski J., Foster J., et al: Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412 (6850):877-884, 2001.
12. Kisliouk T., Levy N., Hurwitz A., Meidan R.: Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J. Clin. Endocrinol. Metab. 88 (8): 3700-3707, 2003.
13. Sugimachi K., Tanaka S., Taguchi K., Aishima S., Shimada M., Tsuneyoshi M.: Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J. Clin. Pathol. 56 (11): 854-860, 2003.
14. Weidner N., Semple J.P., Welch W.R., Folkman J.: Tumor angiogenesis and metastasis-correlation in invasive breast cancer. N Engl J Med 324 (1):1-8, 1991.
15. Asahara T., Kalka C., Isner J. M.: Stem cell therapy and gene transfer for regeneration. Gene Ther. 7(6):451-457, 2000.
16. Rafii S.: Circulating endothelial precursors: mystery, reality and promise. J. Clin. Invest. 105(1):17-19, 2000.
17. Carmeliet P.: Mechanism of angiogenesis and arteriogenesis. Nature Med. 6(4):389-395, 2000.
18. Hellstrom M., Klan M., Lindahl P., Abramsson A., Betsholtz C.: Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth cells and pericytes during embryonic blood vessel formation in the mouse. Development 126(14):3047-3055,1999.
19. Hirsch K. K., Rohovsky S. A., Beck L. H., Smith S. R., D'Amore P. A.: Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84(3):298-305,1999.
20. Lauren J., Gunji Y., Alitalo K.: Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am. J. Pathol. 153(5):1333-1339,1998.
21. Kwak H.J., So J.N., Lee S.J., Kim I., Koh G.Y.: Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 448(2-3): 249-253, 1999.
22. Peters K.G.: Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ. Res. 83(3): 342-343,1998.
23. Holash J., Maisonpierre P.C., Compton D., et al: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (5422): 1994-1998, 1999.
24. Wang H. U., Chen Z., Anderson D. J.: Molecular distinction and angiogenic inter action between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93(5):741-753,1998.
25. Holash J., Maisonpierre P.C., Compton D., et al: Roles of ephrinB ligands and EphB receptors in cardiovascular development demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Gene Dev. 13(3): 295-306,1999.
26. Gerety S. S., Wang H. U., Chen Z., Anderson D. J.: Sysmetrical mutation phenotype of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4(3):403-414, 1999.
27. Maekawa H., Oike Y., Kanda S., et al: Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature. Arterioscler. Thromb. Vasc. Biol. 23 (11):2008-2014, 2003.
28. Zhang X.Q., Takakura N., Oike Y., et al: Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2+ endothelial cells. Blood 98 (4): 1028-1037, 2001.
29. Goi T., Fujioka M., Satoh Y., et al: Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res. 64 (6): 1906-1910, 2004.
30. Zhang L., Yang N., Conejo-Garcia J.R., et al: Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Clin. Cancer Res., 9 (1): 264-272, 2003.
31. Lin R., LeCouter J., Kowalski J., Ferrara N.: Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J. Biol. Chem., 277(10): 8724-8729, 2002.
32. Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D.: Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284(5415):808-812,1999.
33. Bolontrade M.F., Stern M.C., Binder R.L., Zenklusen J.C., Gimenez-Conti I.B., Conti C.J.: Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis 19(12):2107-2113,1998.
34. Bergers G., Brekken R., McMahon G., et al: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2(10):737-744,2000.
35. Frachon S., Gouysse G., Dumorti J., et al: Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J. Hepatol. 34(6):850-857, 2001.
36. Park Y.N., Kim Y.B., Yang K.M., Park C.: Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch. Pathol. Lab. Med. 124 (7):1061-1065, 2000.
37. Yoshiji H., Kuriyama S., Yoshii J., et al: Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. Hepatology 39 (6): 1517-1524, 2004.
38. Meng C., Chen X.: Association of VEGF, uPA, ICAM-1 and PCNA expression with metastasis and recurrence in hepatocellular carcinoma. Chin. J. Surg. 40(9): 67-69, 2002.
39. Moon W.S., Rhyu K.H., Kang M.J., et al: Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? Mod. Pathol. 16 (6): 552-557, 2003.
40. Mitsuhashi N., Shimizu H., Ohtsuka M., et al: Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma. Hepatology 37 (5): 1105-1113, 2003.
41. Yoshiji H., Kuriyama S., Noguchi R., et al: Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice. Gut 54(12):1768-1775, 2005.
42. Liu W., Jung Y.D., Ahmad S.A., et al: Effects of overexpression of ephrin-B2 on tumour growth in human colorectal cancer. Br. J. Cancer 90 (8): 1620-1626, 2004.
43. Rskopf E., Dzienisowicz C., Hilbert T., et al: Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model. Hepatology 41 (6): 1233-1240, 2005.
44. Schmitz V., Kornek M., Hilbert T., et al: Treatment of metastatic colorectal carcinomas by systemic inhibition of vascular endothelial growth factor signaling in mice. World J. Gastroenterol. 11(28):4332-4336, 2005.